176 related articles for article (PubMed ID: 3046955)
1. Dextromethorphan inhibits NMDA-induced convulsions.
Ferkany JW; Borosky SA; Clissold DB; Pontecorvo MJ
Eur J Pharmacol; 1988 Jun; 151(1):151-4. PubMed ID: 3046955
[TBL] [Abstract][Full Text] [Related]
2. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
[TBL] [Abstract][Full Text] [Related]
3. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
Aram JA; Martin D; Tomczyk M; Zeman S; Millar J; Pohler G; Lodge D
J Pharmacol Exp Ther; 1989 Jan; 248(1):320-8. PubMed ID: 2536430
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice.
Leander JD
Epilepsy Res; 1989; 4(1):28-33. PubMed ID: 2666123
[TBL] [Abstract][Full Text] [Related]
5. Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices.
Wong BY; Coulter DA; Choi DW; Prince DA
Neurosci Lett; 1988 Feb; 85(2):261-6. PubMed ID: 2897648
[TBL] [Abstract][Full Text] [Related]
6. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-methyl-D-aspartate antagonists on the cough reflex.
Kamei J; Tanihara H; Igarashi H; Kasuya Y
Eur J Pharmacol; 1989 Sep; 168(2):153-8. PubMed ID: 2691260
[TBL] [Abstract][Full Text] [Related]
8. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.
Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH
Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964
[TBL] [Abstract][Full Text] [Related]
9. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
Marrannes R; Willems R; De Prins E; Wauquier A
Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
[TBL] [Abstract][Full Text] [Related]
11. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.
Daniell LC
Pharmacol Biochem Behav; 1990 May; 36(1):111-5. PubMed ID: 2190239
[TBL] [Abstract][Full Text] [Related]
12. Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants.
Moreau JL; Pieri L; Prud'hon B
Br J Pharmacol; 1989 Nov; 98(3):1050-4. PubMed ID: 2574061
[TBL] [Abstract][Full Text] [Related]
13. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison.
Grigg JJ; Anderson EG
J Pharmacol Exp Ther; 1990 Apr; 253(1):130-5. PubMed ID: 1970359
[TBL] [Abstract][Full Text] [Related]
14. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
[TBL] [Abstract][Full Text] [Related]
15. Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats.
Tang AH; Ho PM
Eur J Pharmacol; 1988 Jun; 151(1):143-6. PubMed ID: 3046954
[TBL] [Abstract][Full Text] [Related]
16. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection.
Tortella FC; Ferkany JW; Pontecorvo MJ
Life Sci; 1988; 42(24):2509-14. PubMed ID: 3374269
[TBL] [Abstract][Full Text] [Related]
18. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Koek W; Woods JH; Winger GD
J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
[TBL] [Abstract][Full Text] [Related]
19. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
France CP; Woods JH; Ornstein P
Eur J Pharmacol; 1989 Jan; 159(2):133-9. PubMed ID: 2651134
[TBL] [Abstract][Full Text] [Related]
20. Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801).
Lyle TA; Magill CA; Britcher SF; Denny GH; Thompson WJ; Murphy JS; Knight AR; Kemp JA; Marshall GR; Middlemiss DN
J Med Chem; 1990 Mar; 33(3):1047-52. PubMed ID: 2155319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
